Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 5-(benzoylamino)-n-(4-chlorophenyl)-3-methyl-4-isothiazolecarboxamide
2. Bacpmi
3. Itcl
4. Wratizolin
1. Wratizolin
2. 51287-57-1
3. Itcl
4. Denotivir [inn]
5. Vratizolin
6. Polvir
7. Vratizolin; Wratizolin
8. 5-benzamido-n-(4-chlorophenyl)-3-methyl-1,2-thiazole-4-carboxamide
9. Denotivir (inn)
10. W656s9i00w
11. 5-benzamido-4'-chloro-3-methyl-4-isothiazolecarboxanilide
12. 5-(benzoylamino)-n-(4-chlorophenyl)-3-methyl-4-isothiazolecarboxamide
13. 5-benzamido-n-(4-chlorophenyl)-3-methylisothiazole-4-carboxamide
14. Vratizolinum
15. T-15
16. Unii-w656s9i00w
17. P-chlorophenylamide Of 3-methyl-5-benzoylaminoizothiazole-4-carboxylic Acid
18. Polvir (tn)
19. 3-methyl-5-benzoylaminoisothiazole-4-carboxylic Acid P-chlorophenylamide
20. 5-(benzoylamino)-n-(p-chlorophenyl)-3-methyl-4-isothiazolecarboxamide
21. Denotivir [mart.]
22. Denotivir [who-dd]
23. Schembl147338
24. Chembl2104203
25. Dtxsid70199278
26. Zinc608304
27. Stl450987
28. 4-isothiazolecarboxamide, 5-(benzoylamino)-n-(p-chlorophenyl)-3-methyl-
29. Ft-0755612
30. D07789
31. Q11693881
32. N-(4-chlorophenyl)-3-methyl-5-[(phenylcarbonyl)amino]-1,2-thiazole-4-carboxamide
| Molecular Weight | 371.8 g/mol |
|---|---|
| Molecular Formula | C18H14ClN3O2S |
| XLogP3 | 4.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 371.0495256 g/mol |
| Monoisotopic Mass | 371.0495256 g/mol |
| Topological Polar Surface Area | 99.3 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 479 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
35
PharmaCompass offers a list of Denotivir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Denotivir manufacturer or Denotivir supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Denotivir manufacturer or Denotivir supplier.
PharmaCompass also assists you with knowing the Denotivir API Price utilized in the formulation of products. Denotivir API Price is not always fixed or binding as the Denotivir Price is obtained through a variety of data sources. The Denotivir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vratizolin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vratizolin, including repackagers and relabelers. The FDA regulates Vratizolin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vratizolin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vratizolin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vratizolin supplier is an individual or a company that provides Vratizolin active pharmaceutical ingredient (API) or Vratizolin finished formulations upon request. The Vratizolin suppliers may include Vratizolin API manufacturers, exporters, distributors and traders.
click here to find a list of Vratizolin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Vratizolin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vratizolin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vratizolin GMP manufacturer or Vratizolin GMP API supplier for your needs.
A Vratizolin CoA (Certificate of Analysis) is a formal document that attests to Vratizolin's compliance with Vratizolin specifications and serves as a tool for batch-level quality control.
Vratizolin CoA mostly includes findings from lab analyses of a specific batch. For each Vratizolin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vratizolin may be tested according to a variety of international standards, such as European Pharmacopoeia (Vratizolin EP), Vratizolin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vratizolin USP).
